Gen9 is the premier next-generation gene synthesis company focused on high-quality, high-throughput, automated production of DNA constructs. Currently, Gen9 offers multiple synthetic biology solutions for researchers who need high quality clonal, sequence-perfect DNA. Our award winning BioFab® process is remarkably flexible and very high throughput; allowing us to make the genes you need quickly at the highest quality available. Gen9 is Powering the Synthetic Biology Revolution.

Company Growth (employees)
Cambridge, US
Size (employees)
19 (est)
Gen9 was founded in 2009 and is headquartered in Cambridge, US

Gen9 Office Locations

Gen9 has an office in Cambridge

Gen9 Data and Metrics

Summary Metrics

Founding Date


Total Funding

$50.1 m

Latest funding size

$25 m

Time since last funding

almost 3 years


Gen9's latest funding round in July 2014 was reported to be $25 m. In total, Gen9 has raised $50.1 m

Gen9 Online and Social Media Presence

Gen9 Company Life and Culture

You may also be interested in